In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology Read more

Antithrombotic therapy in secondary prevention - How long and how strong?


22/02/2017 18:00 22/02/2017 19:00 Europe/Paris Antithrombotic therapy in secondary prevention - How long and how strong? Association of Cardiovascular Nursing and Allied Professions (ACNAP) DD/MM/YYYY
Association of Cardiovascular Nursing and Allied Professions (ACNAP)
Coronary Artery Disease (Chronic)
Myocardial Disease
Risk Factors and Prevention

Focus on

Learning objectives:

  • Guidelines for antiplatelet use after ACS and in CAD
  • Which antiplatelet agent should be given in secondary prevention
  • How long should they be continued?
  • New trials with new antiplatelet agents

This webinar is produced in the framework of the ESC Prevention of CVD Programme, organised by the European Association of Preventive Cardiology (EAPC), the Acute Cardiovascular Care Association (ACCA) and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). 

Watch the webinar recording




Prof Robert StoreyProfessor Robert Storey, FESC
Professor of Cardiology, Department of Infection, Immunity & Cardiovascular Disease,
University of Sheffield, United Kingdom
Academic Director, Cardiology and Cardiothoraci Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust
Director, Cardiovascular Research Unit, Centre for Biomedical Research, Northern General Hospital, Sheffield

Prof Steen KristensenProfessor Steen Dalby Kristensen, FESC
ESC Press Committee Chair
Professor, Consultant Cardiology,
Department of Cardiology,
Aarhus University Hospital, Aarhus, Denmark


Prof Hector BuenoProfessor Héctor Bueno, FESC
Senior Researcher,
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
Past-President (2014-2016) of the Acute Cardiovascular Care Association (ACCA)


Session information

The webinar addresses:

  • Cardiologists and Cardiovascular Specialist, Nurses and other Allied Professionals
  • Multi-disciplinary cardiology teams in hospitals 
  • General Practitioners and other primary care providers

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and Tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (a minima 2 Mbps).